A 64-year-old patient complains of shortness of breath and is cyanotic, sits in a tripod position, with tachypnea. Which medication is appropriate to administer?

Prepare for the Paramedic Readiness Exam 4 with our engaging quiz. Hone your skills with targeted questions, hints, and in-depth explanations. Excel on your exam with confidence!

When airway constriction is causing rapid breathing and cyanosis, the priority is to rapidly open the airways. A short-acting beta-2 agonist inhaled bronchodilator does exactly that by relaxing the smooth muscle surrounding the bronchi, which quickly reduces airway resistance and improves ventilation. This is why a fast-acting inhaled medication is the best immediate choice in an acute bronchospasm scenario like this.

The patient’s tripod position, tachypnea, and cyanosis point to significant bronchospasm with hypoxemia. Inhaled albuterol directly targets that problem and acts within minutes to relieve bronchoconstriction, improve airflow, and ease work of breathing.

Epinephrine can be used in life-threatening bronchospasm or anaphylaxis, but it’s not the first-line, single-agent treatment for a standard acute bronchospasm unless there’s a specific anaphylactic trigger or severe, unresponsive symptoms. Prednisone is a systemic anti-inflammatory that takes hours to days to help and won’t provide the rapid relief needed here. Ipratropium is an anticholinergic bronchodilator that can help in some circumstances, often as an adjunct but not as the primary fast-acting relief in this acute setting.

So, the quickest, most effective option to relieve the acute airway obstruction in this patient is albuterol.